High Tide (NASDAQ:HITI – Get Free Report) and Glucose Health (OTCMKTS:GLUC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.
Insider and Institutional Ownership
4.5% of High Tide shares are held by institutional investors. 12.4% of High Tide shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares High Tide and Glucose Health”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| High Tide | $381.22 million | 0.60 | -$3.19 million | ($0.08) | -32.38 |
| Glucose Health | $380,000.00 | 22.73 | -$320,000.00 | ($0.03) | -14.08 |
Glucose Health has lower revenue, but higher earnings than High Tide. High Tide is trading at a lower price-to-earnings ratio than Glucose Health, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations for High Tide and Glucose Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| High Tide | 1 | 0 | 2 | 1 | 2.75 |
| Glucose Health | 0 | 0 | 0 | 0 | 0.00 |
High Tide currently has a consensus price target of $6.13, suggesting a potential upside of 136.49%. Given High Tide’s stronger consensus rating and higher possible upside, equities analysts plainly believe High Tide is more favorable than Glucose Health.
Profitability
This table compares High Tide and Glucose Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| High Tide | -1.66% | -6.50% | -3.84% |
| Glucose Health | -108.70% | N/A | N/A |
Risk & Volatility
High Tide has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Glucose Health has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500.
Summary
High Tide beats Glucose Health on 8 of the 15 factors compared between the two stocks.
About High Tide
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. It operates licensed retail cannabis stores; and provides data analytics services. In addition, the company manufactures and distributes consumption accessories. Further, it sells its products through online sales via e-commerce platform. The company offers its products under the Daily High Club, DankStop, FABCBD, GC, Nuleaf, Smoke Cartel, and Blessed CBD brands. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Receive News & Ratings for High Tide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for High Tide and related companies with MarketBeat.com's FREE daily email newsletter.
